Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Event Free Survival at 12 Months and 24 Months as Predictors for Outcome of Systemic Peripheral T Cell Lymphoma: Analysis of Nationwide Thai Lymphoma Study Group

Hematological Oncology

English

Cytokine Release Syndrome and Neurotoxicity by Baseline Tumor Burden in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel

Hematological Oncology

English

Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy

Hematological Oncology

English

Dual Inhibition of Ezh2 and Hdac Is Synergistic in Ezh2 Dysregulated Lymphomas

Hematological Oncology

English

BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial

Hematological Oncology

English

Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo

Hematological Oncology

English

Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial

Hematological Oncology

English

Combination of Idarubicin, Vinblastine, Dacarbazine, and Gemcitabine (IVDG) as Therapy for Elderly Patients With Hodgkin Lymphoma With Cardiac and Pulmonary Comorbidity

Hematological Oncology

English

Bone Marrow Involvement, but No Blood Involvement, Impairs Survival in Angioimmunoblastic T Cell Lymphoma: An Ancillary Study of the Revail Trial

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Event Free Survival at 12 Months and 24 Months as Predictors for Outcome of Systemic Peripheral T Cell Lymphoma: Analysis of Nationwide Thai Lymphoma Study Group

Cytokine Release Syndrome and Neurotoxicity by Baseline Tumor Burden in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel

Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy

Dual Inhibition of Ezh2 and Hdac Is Synergistic in Ezh2 Dysregulated Lymphomas

BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial

Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo

Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial

Combination of Idarubicin, Vinblastine, Dacarbazine, and Gemcitabine (IVDG) as Therapy for Elderly Patients With Hodgkin Lymphoma With Cardiac and Pulmonary Comorbidity

Bone Marrow Involvement, but No Blood Involvement, Impairs Survival in Angioimmunoblastic T Cell Lymphoma: An Ancillary Study of the Revail Trial